Urgent Ramipril Recall: Crescent Pharma Capsules Withdrawn

Ramipril recall has been issued by Crescent Pharma Limited for a specific batch of Ramipril 2.5mg capsules due to a packaging mistake. This error potentially means that some cartons contain blister strips of the higher dosage, specifically Ramipril 10mg. The recall follows a report where a healthcare professional discovered two blister strips of Ramipril 10mg capsules inside a sealed box of Crescent Pharma Limited Ramipril 2.5mg capsules. Both batches were produced at the same facility, suggesting that the packaging error occurred during the carton assembly process. Ramipril is a medication prescribed for managing hypertension (high blood pressure), kidney diseases, and heart failure. Dr. Alison Cave, MHRA Chief Safety Officer, stated: "If you are using Crescent Pharma Limited Ramipril 2.5mg capsules, please verify the batch number GR155023 on the packaging. This information, along with the expiry date, can be located on the outer carton. If you possess this batch, ensure the medication strength on the carton corresponds with the blister strips inside. "Should the 2.5mg carton of Crescent Pharma Limited Ramipril hold blister strips labeled as Ramipril 10mg capsules, do not consume the medication and contact your pharmacy immediately. If the carton contains the correctly labeled Ramipril 2.5mg capsules, no further action is needed, and you can continue your prescribed medication as usual. "If you have received any affected packs or suspect you’ve taken Ramipril 10mg capsules in error and are experiencing side effects, seek medical assistance right away. "Symptoms may include dizziness, fainting, fatigue, or changes in kidney function, which can be more severe for certain patients. A healthcare professional should evaluate any effects from taking an incorrect dose of Ramipril to determine if any tests are necessary. "If you possess this batch, bring the leaflet that came with your medicine, along with any remaining tablets, to your pharmacy or GP. Also, remember to report any suspected side effects through the MHRA Yellow Card scheme." The MHRA has informed pharmacies and healthcare providers to cease distribution of the impacted batch and return any remaining stock to their suppliers. For further information about this Ramipril recall, visit the [MHRA](https://www.gov.uk/government/news/precautionary-recall-of-blood-pressure-medication-crescent-pharma-limited-ramipril-25mg-capsules) or learn more about medication safety at [FDA](https://www.fda.gov). For related articles, please check our [healthcare section](https://www.globemigrant.com/healthcare) and [news updates](https://www.globemigrant.com/news).

No Result